Publication | Closed Access

Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland☆

PsychiatryPsychotropic MedicationPharmacologyDepressionPsychopharmacologyNeuropharmacologyMajor Depressive DisorderSocial SciencesPharmacotherapyMood DisordersPsychiatric DisorderMental HealthEconomic EvaluationMedicineVenlafaxine XrPsychopathology